Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

ID Biomedical licenses oral E. coli vaccine technology

April 25, 2000

New controlled-release, microencapsulated HBV vaccine prepared in China

April 24, 2000

NIH research sheds light on chronic hepatitis C

April 24, 2000

Glaxo Wellcome obtains nonexclusive HCV license from Chiron

April 20, 2000

Adefovir dipivoxil shows activity against lamivudine-resistant HBV

April 20, 2000

Dainippon describes motility-enhancing activity of 5-HT4 receptor agonists

April 18, 2000

Isis Pharmaceuticals completes financing with Elan for HCV joint venture

April 18, 2000

Kosan Biosciences awarded SBIR grant to develop motilin receptor agonists

April 18, 2000

Maxamine plus IFN-alpha yields up to 69% complete response in HCV

April 17, 2000

Novel DELTA-lactones with utility in inflammatory conditions disclosed by Inflazyme

April 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...